NaviGate Cardiac Structures Overview

  • Founded

  • 2011

Founded
  • Status

  • Private

  • Employees

  • 3

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $10M

  • Investors

  • 3

NaviGate Cardiac Structures General Information

Description

Developer of transcatheter designed to treat atrioventricular valve regurgitation. The company's transcatheter device is an atrioventricular valved stent for the replacement of a failing tricuspid valve, enabling physicians to treat functional tricuspid regurgitation.

Contact Information

Website
www.navigatecsi.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Other Devices and Supplies
Primary Office
  • 20412 James Bay Circle
  • Lake Forest, CA 92630
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NaviGate Cardiac Structures Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 25-Oct-2018 $10M 0000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Apr-2014 Completed Generating Revenue
To view NaviGate Cardiac Structures’s complete valuation and funding history, request access »

NaviGate Cardiac Structures Patents

  • 21

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

NaviGate Cardiac Structures Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200155307-A1 Valved stent for orthotopic replacement of dysfunctional cardiac valve and delivery system Active 14-May-2017 0000000000 0
EP-3624728-A1 Valved stent for orthotopic replacement of dysfunctional cardiac valve and delivery system Pending 14-May-2017 0000000000
EP-3624728-A4 Valved stent for orthotopic replacement of dysfunctional cardiac valve and delivery system Pending 14-May-2017 0000000000 0
US-10973633-B2 Valved stent for orthotopic replacement of dysfunctional cardiac valve and delivery system Active 14-May-2017 0000000000
AU-2018269945-A1 Valved stent for orthotopic replacement of dysfunctional cardiac valve and delivery system Inactive 14-May-2017 A61F2/2418
To view NaviGate Cardiac Structures’s complete patent history, request access »

NaviGate Cardiac Structures Executive Team (5)

Name Title Board Seat Contact Info
Rodolfo Quijano MD President
Neville Jehariajah Chief Financial Officer
You’re viewing 2 of 5 executive team members. Get the full list »

NaviGate Cardiac Structures Board Members (1)

Name Representing Role Since
Akhil Saklecha MD Self Board Member 000 0000
To view NaviGate Cardiac Structures’s complete board members history, request access »

NaviGate Cardiac Structures Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NaviGate Cardiac Structures Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
iVascular Corporation Minority 000 0000 000000 0
Cleveland Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
Runnymede Investments Family Office Minority 000 0000 000000 0
To view NaviGate Cardiac Structures’s complete investors history, request access »

Ready to get started?

Request a free trial